(Q35018415)

English

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with specia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20675706%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20675706%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

0 references

0 references

0 references

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

James B Galloway

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20675706%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20675706%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20675706%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Deborah P.M. Symmons

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20675706%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Kimme L. Hyrich

2

object named as

Kimme L Hyrich

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20675706%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

3

object named as

Louise K Mercer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20675706%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

British Society for Rheumatology Biologics Register

11

object named as

British Society for Rheumatology Biologics Register

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20675706%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

7

object named as

Kath D Watson

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20675706%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

British Society for Rheumatology Biologics Register Control Centre Consortium

10

object named as

BSRBR Control Centre Consortium

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20675706%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Andrew P Ustianowski

6

object named as

Andrew P Ustianowski

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20675706%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Bo Fu

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20675706%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

31 July 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20675706%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20675706%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

50

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20675706%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20675706%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

124-131

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20675706%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Initiation of rheumatoid arthritis treatments and the risk of serious infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105607

8 July 2018

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105607

8 July 2018

Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105607

8 July 2018

Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105607

8 July 2018

The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105607

8 July 2018

The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105607

8 July 2018

Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105607

8 July 2018

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105607

8 July 2018

The British Society for Rheumatology biologics register

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105607

8 July 2018

Signalling pathways of the TNF superfamily: a double-edged sword

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105607

8 July 2018

Predictors of infection in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105607

8 July 2018

Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105607

8 July 2018

Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105607

8 July 2018

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105607

8 July 2018

Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105607

8 July 2018

Experimental therapies for sepsis directed against tumour necrosis factor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105607

8 July 2018

Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ242

21 January 2018

Infections in patients with rheumatoid arthritis treated with biologic agents

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ242

21 January 2018

Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ242

21 January 2018

Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ242

21 January 2018

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ242

21 January 2018

Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105607

25 October 2018

Early rheumatoid arthritis patients: relationship of age

1 reference

https://pubmed.ncbi.nlm.nih.gov/20675706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of immune complex clearance by TNF-alpha in a murine model

1 reference

https://pubmed.ncbi.nlm.nih.gov/20675706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20675706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/20675706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolerance and effectiveness of anti–tumor necrosis factor α therapies in elderly patients with rheumatoid arthritis: A population-based cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20675706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20675706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infection in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20675706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TNF receptors in murine Candida albicans infection: evidence for an important role of TNF receptor p55 in antifungal defense

1 reference

https://pubmed.ncbi.nlm.nih.gov/20675706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exacerbation of murine Pneumocystis carinii infection by adenoviral-mediated gene transfer of a TNF inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/20675706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/RHEUMATOLOGY/KEQ242

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20675706%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20675706%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20675706%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35018415&oldid=2040265821"